A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Diseases Interventions: Drug: Cotadutide 100 micrograms; Drug: Cotadutide 300 micrograms; Drug: Cotadutide 600 micrograms; Drug: Semaglutide; Drug: Placebo Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Research | Study | Urology & Nephrology